The Antibody Lab reports positive evaluation of Horizon 2020 project

Name: _pk_id Used for : Is used to store an unique ID for each user Duration : 13 Months
Name: &nbsp;_pk_ses, _pk_cvar, _pkhsr Used for :&nbsp;Session cookies that store temporary data Duration :&nbsp;30 minutes
Name: mtm_consent Used for : Stores cookie preferences Duration : 30 years

The Antibody Lab with its Horizon 2020 project proposal on clinical validation of its proprietary marker NT-proCNP for pregnancy complications was successful in a highly competitive evaluation process. The proposal has been recommended for funding by other sources due to budget constraints of the EC.

Sorry, this entry is only available in German!

The sender takes full responsibility for the content of this news item. Content may include forward-looking statements which, at the time they were made, were based on expectations of future events. Readers are cautioned not to rely on these forward-looking statements.

As a life sciences organization based in Vienna, would you like us to promote your news and events? If so, please send your contributions to news(at)lisavienna.at.

The Antibody Lab reports positive evaluation of Horizon 2020 project

ABOL – Austrian Barcode of Life: eine Mission für Biodiversität in Österreich

vetmeduni Vienna: New insights and pioneering work in targeted therapy against blood cancer

Uni Vienna: How soil microbes survive in harsh desert environments